Detalhe da pesquisa
1.
The Efficacy and Effectiveness in HBA1C-Lowering is Dependent on Baseline Body Mass Index (BMI) for Sitagliptin but not Canagliflozin in the Treatment of Type 2 Diabetes Mellitus (T2DM).
Value Health
; 17(7): A334, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27200590
2.
Circulating tumor cells as a biomarker for response to therapy in multiple myeloma patients treated within the GMMG-MM5 trial.
Bone Marrow Transplant
; 52(8): 1194-1198, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28504661